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Preface 
This report is the result of a National Nanotechnology Initiative (NNI) Sensor Fabrication, Integration, 
and Commercialization Workshop, convened September 11–12, 2014, in Arlington, VA. This report was 
made possible with the help of the Nanoscale Science, Engineering, and Technology (NSET) 
Subcommittee of the National Science and Technology Council and with staff support from the National 
Nanotechnology Coordination Office (NNCO). The workshop and resulting report build on efforts by 
Federal agencies participating in the Nanotechnology Signature Initiative Nanotechnology for Sensors 
and Sensors for Nanotechnology: Improving and Protecting Health, Safety, and the Environment (Sensors 
NSI). The Sensors NSI exists to address the opportunity of using nanotechnology to advance sensor 
development as well as the challenges of developing sensors to keep pace with the increasingly 
widespread use of engineered nanomaterials. The Sensors NSI has built upon existing NNI member 
agency efforts to support research on nanomaterial properties as well as the development of device 
and supporting technologies that enable next-generation sensing of biological and chemical materials, 
including those on the nanometer scale. 
In his landmark speech at the California Institute of Technology on January 21, 2000, in which he 
announced the establishment of a new national initiative in nanotechnology, President Clinton imagined 
the possibility of “detecting cancerous tumors that are only a few cells in size.” Federal agencies 
participating in the NNI also recognize the considerable potential for nanotechnology to enhance the 
development of inexpensive, portable devices that can rapidly detect, identify, and quantify a vast array 
of biological and chemical entities for multiple applications. However, the sensor development 
community is currently facing key challenges related to standards, technology development and 
validation, and manufacturing that inhibit progress. Therefore, the NNI workshop brought together 
some of the Nation’s leading experts in sensor technologies from industry, academia, and Government 
to identify and discuss challenges that are faced by the sensor development community during the 
fabrication, integration, and commercialization of sensors. Meeting participants further identified a 
range of actions that could help mitigate these challenges and facilitate the commercialization of 
nanosensors. Workshop discussions also informed the development of the Sensors NSI web portal, 
which can now be accessed at www.nano.gov/SensorsNSIPortal. This web resource was created to share 
information on the sensors development landscape, including Federal program and funding opportunities, 
federally supported facilities, regulatory guidance, and published standards. 
On behalf of the NSET Subcommittee, we thank Dorothy Farrell, Mark Hoover, Lisa Friedersdorf, Hongda 
Chen, Paul Shapiro, and Kim Sapsford for taking the lead in organizing this workshop. We also thank the 
speakers, discussion leaders, and other participants for their valuable contributions as well as the NNCO 
staff for logistical support and assistance in planning and executing this meeting. We trust that you will 
find this report to be a valuable resource for the NNI, the nanomaterials and sensor communities, and 
all other stakeholders as we work together to promote the NNI’s vision of creating “a future in which the 
ability to understand and control matter at the nanoscale leads to a revolution in technology and 
industry that benefits society.” 
 
Lori Henderson Lloyd Whitman Michael Meador 
Co-Chair Co-Chair Director 
NSET Subcommittee NSET Subcommittee NNCO 
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Executive Summary 
This report is a summary of the technical presentations and discussions that occurred at the National 
Nanotechnology Initiative (NNI) Sensor Fabrication, Integration, and Commercialization Workshop, held 
at the National Science Foundation (NSF) on September 11–12, 2014. The goal of the workshop was to 
identify and discuss challenges that are faced by the sensor development community during the 
fabrication, integration, and commercialization of sensors, particularly those employing or addressing 
issues of nanoscale materials and technologies. 
Discussions at the workshop highlighted key challenges for the sensor development community, 
specifically related to standards, technology development and validation, manufacturing, and 
commercialization. These challenges include: 
• Timely development of nanosensor-specific consensus standards. 
• Access to rapid and precise characterization tools as well as testbeds designed for specific 
sensor applications. 
• Scarcity of cost-effective semiconductor device foundries in the United States for low-to-
medium-volume prototype production. 
• Understanding and navigating the regulatory process that applies to specific sensor products 
and determining relevant points of contacts in Federal agencies. 
• The ability to anticipate unintended consumer use of sensor products, which could possibly 
place consumers at risk. 
• Decreasing financial support from the venture capital community. 
Sensor developers and Federal agencies participating in the workshop identified a range of actions that 
could help address these challenges and facilitate the commercialization of nanosensors, which include: 
• Enhancing communication among researchers, developers, manufacturers, customers, and the 
Federal Government agencies that support and regulate sensor development. 
• Leveraging resources by building testbeds that are easily accessible to sensor developers and 
improving access of university and private researchers to federally supported pilot-scale 
foundries. 
• Encouraging sensor developers to consider and prepare for market and regulatory requirements 
early in the development process. 
In response to these actions and discussions at the workshop, the Nanotechnology Signature Initiative 
Nanotechnology for Sensors and Sensors for Nanotechnology: Improving and Protecting Health, Safety, 
and the Environment resources web portal [1] was created to share information on the sensors 
development landscape, including funding agencies and opportunities, federally supported facilities, 
regulatory guidance, and published standards. Ongoing dialogue and collaboration among various 
stakeholder groups will be critical to effectively transitioning nanosensors to market and to meeting the U.S. 
need for a reliable and robust sensor infrastructure. 
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1. A Life Cycle Approach to Sensors 
Development 
A sensor is a device that responds to a physical, chemical, and/or biological stimulus and converts its 
response into an output [2]. Sensors are increasingly being used in settings ranging from health 
diagnostics and chemical-biological threat detection to agricultural applications such as building crop 
yield maps. The Nanotechnology Signature Initiative Nanotechnology for Sensors and Sensors for 
Nanotechnology: Improving and Protecting Health, Safety, and the Environment (hereafter, “Sensors 
NSI”) is the fifth Nanotechnology Signature Initiative launched by the agencies of the U.S. National 
Nanotechnology Initiative (NNI). NNI agencies recognize the considerable potential for nanotechnology 
to enhance the development of inexpensive, portable devices that can rapidly detect, identify, and 
quantify biological and chemical substances. Agencies participating in the Sensors NSI coordinate efforts 
(see Appendix A) and stimulate existing and emerging projects to explore the use of nanotechnology in 
two thrust areas [3]: 
• Using nanotechnology and nanoscale materials to build more sensitive, specific, and adaptable 
sensors in order to overcome the technical shortcomings of conventional sensors (Thrust 1). 
• Developing new sensors to detect engineered nanomaterials across their life cycles, in order to 
assess the potential impact on health, safety, and the environment (Thrust 2). 
The Life Cycle Approach to Sensors Development 
The sensors development life cycle defines steps that will enable successful and safe use of a 
nanosensor device throughout its lifetime [4, 5]. Widespread adoption of Thrust 1 or Thrust 2 
nanosensors requires support at each step of the development life cycle, from conception to retirement, 
as shown in Figure 1 below. 
 
Figure 1. Diagram summarizing life cycle stages for development and application of sensors [3]. 
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The life cycle steps highlighted in Figure 1 have been defined previously [4, 5]. Through an ongoing 
process of documentation and improvement, the interrelated life cycle activities enable an instrument 
to progress logically from the development phase involving regulatory review through the user-
application phase of what can be viewed as post-market surveillance. In brief: 
• The mission evaluation step serves the role of “problem formulation” and defines the objective 
of the measurement and identifies constraints on when, where, or by whom the instrument is to 
be used. Most importantly, it also identifies the value proposition, other candidate technologies, 
and clarifies the need for the instrument and optimal design endpoints. 
• The research and development step first determines the circumstances in which the specific 
instrument design would meet the intended specifications. Understanding such requirements 
would allow manufacturers to produce a sensor that is likely to meet the engineering 
requirements set in the mission evaluation step. 
• Prototype testing and type testing define and document the performance and limitations of the 
new sensor. The major difference between these two steps is that type testing is a formal 
process to meet specific requirements set by national and international standard organizations.  
• Production control testing ensures that manufactured sensors meet critical user requirements 
for reliability and performance in accordance with documented procedures for quality 
management and assurance. 
• Although positioned between the sensor development and application steps, training is a crucial 
cross-cutting step that is conducted at each phase of the life cycle. Training requirements apply 
to a wide range of individuals, from the technicians in the manufacturing line to the ultimate 
users. 
• Acceptance testing, done by the organization that will deploy the sensor, ensures that each 
instrument has arrived undamaged and meets the specifications for its intended use. 
• Although initial calibration can be performed as part of production control testing, it is generally 
performed after acceptance testing and before initial use of the instrument. 
• Functional checks determine that an instrument is operational and capable of performing its 
intended function. Software development can play a critical role in enabling automatic 
diagnostics and self-checking features. 
• Operational experience involves the evaluation of actual data collection to ensure proper sensor 
operation and interpretation. Careful tracking of operational experience can provide early 
evidence of sensor performance inconsistencies. 
• Maintenance and recalibration ensures that sensor components, including replacement parts or 
alterations, have been successfully integrated into the supply chain and are equivalent to those 
specified by the manufacturer. Modified sensors, in particular, would require additional 
performance tests and documentation prior to issuance for field use, unless the modifications 
are shown not to affect the instrument performance or intended use for regulatory purposes. 
• Periodic performance testing is essential to ensuring that the sensor continues to provide 
adequate performance under the intended and actual conditions of use. 
1. A Life Cycle Approach to Sensors Development 
Proceedings: NNI Sensor Fabrication, Integration, and Commercialization Workshop 
3 
The Sensors NSI Request for Information: Relating Stakeholder Inputs to the 
Sensors Development Life Cycle 
NNI agencies participating in the Sensors NSI released a Request for Information (RFI) on October 1, 
2013, to gather input from the public on specific needs for the accelerated development and 
commercialization of nanosensors [6]. The request focused on the following themes: standards, testing, 
manufacturing, commercialization, and regulation. The fifteen thematic questions included in the RFI 
could be summarized by the following general questions: 
• What are the existing resources, facilities, and capabilities for sensor development? 
• What are current testing and manufacturing practices in sensor development? 
• How well do the existing resources, facilities, and capabilities meet sensor development needs? 
• What new resources, facilities, capabilities are needed? 
• How can we prioritize among needs? 
• What are the new tools, processes, and applications for sensors that will have the largest 
immediate impact? 
Responses collected from this RFI included diverse perspectives from trade groups, academia, technical 
experts, social scientists, and industry [7]. Common themes were identified based on these inputs. For 
example, the need to improve communication and collaboration among stakeholders was a common 
response. There was agreement that, as sensors become the backbone of the “Internet of Things” and 
software development continues to play a crucial role in sensor performance, data security is necessary 
for the acceptance of ubiquitous sensing. Responses indicated that access to test conditions beyond 
standard laboratory environments and closer to field use is critical for sensor development, and that 
transition of prototype sensors from research to commercial use depends on the availability of realistic 
testbeds. Other needs highlighted in the responses to the Sensors NSI RFI included: 
• Additional standards to guide performance and operability of sensors; for example, standards to 
guide measures and reporting of sensitivity and accuracy by sensing. 
• Standards for interoperability and data security. 
• Access to restricted facilities such as biohazard laboratories and to advanced equipment for 
testing sensors in physiologically or environmentally relevant conditions. 
• Guidance on how to better engage with appropriate contacts within regulatory agencies. 
Examples of promising Thrust 1-type sensor applications mentioned in the RFI responses include 
physiological or metabolic nanosensing, medical diagnostics, gas-phase nanosensing, and “agrifood”-
based applications. Responses also highlighted the promise of distributed nanosensor network 
applications, not only for a specific measurement field, but across several stages of a product life cycle. 
Furthermore, adapting sensors to detect nanomaterials for environmental, health, and safety 
applications (i.e., Thrust 2) could represent a critical component of safety and quality control for the 
manufacturing of nanosensors, as well as for tracking the fate and transport of nanoscale components 
of sensors and other products throughout their life cycles. To achieve this goal, it will be necessary to 
recognize those nanoscale properties that distinguish nanomaterials from chemical species or that 
distinguish engineered nanomaterials from incidental (or naturally occurring) nanomaterials in a matrix. 
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2. Sensors Development and 
Commercialization 
The Sensor Fabrication, Integration, and Commercialization Workshop gathered experts from a wide 
range of application areas, stages of product development, and manufacturing of sensors. This section 
of the report summarizes keynotes and panel presentations that comprised the first day of the 
workshop. 
Navigating from Lab to Market 
Sydney Ulvick  
In-Q-Tel 
Launched in 1999 as an independent, not-for-profit organization, In-Q-Tel (IQT) was created to meet the 
technology needs of the U.S. Intelligence Community by identifying and investing in venture-backed 
technology startups [8]. IQT investments aim to accelerate product development and add mission-
critical capabilities for the delivery of cutting-edge technologies to the intelligence community. 
Dr. Ulvick discussed essential strategies for successful nanosensor commercialization based on IQT’s 
experience with sensors and related technologies. In general, targeting a specific market segment and 
business position are both critically important for successful commercialization of sensors. A high 
priority should be placed on building value in order to sustain a profitable market position. This requires 
an enterprise to recruit staff and board members with appropriate expertise in marketing and business 
management, rather than embracing a singular focus on research and technology development. Also 
crucial to the success of a startup company are thoughtful investors capable of accurately assessing the 
technology’s value. Government funding can facilitate this value-building step by extending non-dilutive 
grant support during the initial stages of the sensor development life cycle. 
Small Business Panel Presentations 
Abhishek Motayed 
N5 Sensors 
Ray Chen  
Omega Optics 
Steve Gibbons 
Brewer Science 
Omowunmi Sadik 
Binghamton University, State University of New York (SUNY)  
Four members of the small business community and academia participated in a panel to present 
perspectives on sensor development issues ranging from prototype development to market launch. The 
panelists listed above, were from the following enterprises: 
• N5 Sensors, a University of Maryland spin-off founded in early 2012. It commercializes low-
power, chip-scale microsensor arrays that can detect various toxic and hazardous gases present 
in air [9]. 
2. Sensors Development and Commercialization 
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• Omega Optics, founded in 2001, is currently based in Austin, Texas. The company develops and 
commercializes lightwave components using planar integrated polymer and silicon waveguide 
technology [10]. 
• Brewer Science, founded in 1981, is currently headquartered in Rolla, Missouri. The company 
focuses on the development and manufacturing of innovative materials, processes, and 
equipment for the reliable fabrication of cutting-edge microdevices [11]. 
• Professor Sadik’s group at the Department of Chemistry at SUNY Binghamton has developed a 
portable, fully autonomous, and remotely operated sensing device, the “Ultra-Sensitive Portable 
Capillary Sensor” (U-PAC™), with funding from the Department of Defense. U-PAC has been 
tested for a range of biological and environmental applications, including the detection of 
biological threat agents (e.g., anthrax, Bacillus globigii, toxins, and live cells), diagnosis of 
diseases such as cancer, and detection of food poisoning [12]. 
Several persistent challenges faced by the small business community were discussed by the panel (see 
Manufacturing and Commercialization sections of Chapter 4 for additional details). One major challenge 
is the limited availability of test facilities to validate sensor reliability and performance in preparation for 
field testing. Additional standards are needed to guide performance metrics for sensitivity and accuracy 
by sensing applications. Panel members also felt constrained by manufacturing services provided by 
semiconductor device fabrication facilities in the United States that have not been cost-effective for 
small-capacity orders. Finally, additional clarity on the regulatory implications of the use of 
nanomaterials in sensors would greatly benefit the small business community, including relevant 
regulation of factory operation and product disposal by the U.S. Environmental Protection Agency (EPA) 
and the Occupational Safety and Health Administration (OSHA), as well as regulation of the safety and 
performance of finished products by the Food and Drug Administration (FDA) and the Consumer Product 
Safety Commission (CPSC). 
Case Study on Commercialization Success 
Ernest Streicher 
John Deere 
John Deere is an American company that manufactures agricultural, construction, and forestry 
machinery, parts, and equipment [13]. The company portfolio covers multiple aspects of the agricultural 
technology production system, from basic mechanization, scale, and productivity, to intelligent 
equipment and integrated solutions [14]. Sensing applications at John Deere include measuring various 
parameters of equipment functionality, including machine control (pressure, position, and speed), crop 
output (yield, weight, and moisture), and sample collection (soil characteristics, grain quality, moisture, 
and oil condition). The scale of potential sensing needs in the agricultural sector can be overwhelming, 
with millions of sensors needed for farms, billions for agronomic zones, and trillions for individual plants. 
Integration of data in large-scale measurement systems is crucial, as is the reliability of sensors in the 
field, which can involve challenging environments with large variations in temperature, vibration, dust, 
and chemical exposure. Representative sampling is a challenge in agricultural applications, as delicate 
crops can shift position with wind and rain and must be measured by non-contact sampling methods. 
Variations in ground conditions (e.g., soil composition, water content, and topology) across a field 
further complicate sampling. A case study on the commercialization of a fluid property sensor 
highlighted the importance of building value before entering a market and being able to quickly adapt to 
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shifts in market behavior. For example, consumer needs for a sensor product might change by the time 
the product is developed and released to the market. Dr. Streicher saw unique opportunities for 
nanotechnology to meet the needs for remote sensing and increased measurement points for higher-
resolution yield maps in industrial agriculture, and to enhance the range of parametric data that is 
captured by current sensing platforms. 
Navigating the Regulatory Process 
Kevin Lorick 
Food and Drug Administration1 
The framework for FDA’s regulation of devices is based on several statutes [15]: the Federal Food, Drug, 
and Cosmetic Act (the FD&C Act) and the Public Health Service Act. These laws have been amended over 
the years [16], for example by the Medical Device Amendments of 1976, the FDA Modernization Act of 
1997, the Medical Device User Fee and Modernization Act of 2002, the FDA Amendments Act of 2007, 
and the FDA Safety and Innovation Act of 2012. In vitro diagnostic (IVD) products are a subset of devices 
that are “reagents, instruments, and systems intended for use in the diagnosis of disease or other 
conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent 
disease or its sequelae. Such products are intended for use in the collection, preparation, and 
examination of specimens taken from the human body. These products are devices as defined in section 
201(h) of the Federal Food, Drug, and Cosmetic Act, and may also be biological products subject to 
section 351 of the Public Health Service Act” [17]. Detailed information on how to market a device may 
be found on FDA’s website [18]. 
The classification of an IVD is risk-based and is determined, in part, by the intended use of the device 
[19]; here, calculation of risk is largely based on the consequence of a false result. Intended use of an 
IVD encompasses a device’s indications for use, which is defined as a general description of the disease 
or condition that the device will diagnose, treat, prevent, cure, or mitigate, including a description of the 
patient population for which the device is intended. For IVDs, the specific type of specimen to be tested 
may also affect the intended use. 
The Center for Devices and Radiological Health (CDRH) is responsible for the regulation of most devices 
within FDA. FDA categorizes devices into one of three classes [20]: Class I, which are generally for low- to 
moderate-risk devices; Class II, generally for moderate- to high-risk devices; and Class III, generally for 
the most high-risk devices and for many devices with novel intended uses. General controls are 
applicable to all devices regardless of class [21]. General controls include an obligation for registration of 
manufacturing establishments and listing of the devices produced. Many devices must be manufactured 
in a controlled manner following Good Manufacturing Practices (GMP) as per Title 21 Code of Federal 
Regulations (CFR) Part 820 [22]. Manufacturers generally must submit reports of certain adverse events 
and of corrections and removals, follow general device labeling provisions, and maintain FDA-required 
records reports. IVDs are also subject to additional, complementary labeling requirements [23]. 
Devices that fall into Class II are subject to general and special controls. These typically require a 
Premarket Notification, according to section 510(k) of the FD&C Act. Special controls are additional 
requirements for devices when general controls alone are insufficient to provide a reasonable assurance 
                                                          
1 CDRH currently has no published device-specific policy concerning nanotechnology. For FDA guidance on use of 
nanotechnology in FDA-regulated products generally, see Reference 25. All opinions expressed here are Dr. Lorick’s and do not 
reflect official FDA policy on nanotechnology. 
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of the safety and effectiveness of a device [21]. Generally, Class III devices also require submission of a 
Premarket Approval application (PMA) and are subject to certain other requirements, which may include 
premarket inspection of manufacturing and clinical sites, annual reporting, and prior approval of most 
significant changes to the device design or manufacturing processes [21]. 
FDA has been working to address the challenges that nanotechnology presents [24, 25] and has 
provided guidance for the use of nanotechnology in FDA-regulated products, including medical devices. 
As described in FDA guidance, FDA will regulate nanotechnology products under existing statutory 
authorities, in accordance with the specific legal standards applicable to each type of product under its 
jurisdiction. FDA considers the current framework for safety assessment sufficiently robust and flexible 
to be appropriate for a variety of materials, including nanomaterials. Issues such as the safety, 
effectiveness, public health impact, or the regulatory status of nanotechnology products are currently 
addressed on a case-by-case basis using FDA’s existing review processes [25]. 
Simply using nanotechnology in the manufacture of a device does not necessarily cause it to fall into a 
different classification than similarly marketed Class I or II devices. Such nanotechnology-enabled 
devices may still be determined to be substantially equivalent to legally marketed devices. If the 
nanotechnology enables a device to function through different principles than the predicate, it likely will 
not be considered substantially equivalent to the predicate, but the risk associated with the new device 
still may not be considered high. As with non-nanotechnology products, in such cases where a 
nanotechnology product is determined to be a unique device, the de novo classification process may 
allow a pathway to Class I or Class II for which general controls or general and special controls provide a 
reasonable assurance of safety and effectiveness, but for which there is no legally marketed predicate 
device. If classified as Class I or II through the de novo process, similar devices could come to market as 
510(k)-exempt devices or by use of the 510(k) pathway rather than via PMA [26]. 
In addition, the investigational device exemption (IDE) regulations allow an investigational device to be 
used in a clinical study in order to collect safety and effectiveness data [27]. Clinical studies are most 
often conducted to support PMAs (a few 510(k) submissions require clinical data). While each device 
and study is different, most IVD investigations are exempt from IDE requirements if the IVD test meets 
certain requirements, including being noninvasive, not requiring an invasive sampling procedure that 
presents significant risk, not by design or intention introducing energy into a subject, and not being used 
as a diagnostic procedure without confirmation of the diagnosis by another, medically established 
diagnostic product or procedure [28]. 
An important review question when assessing the safety and effectiveness of a nanosensor is whether 
the use of nanotechnology makes the device “better.” There is a wide range of engineered 
nanomaterials with unique physical and chemical properties that lend themselves to many potential 
biomedical applications. This variety in properties extends to diverse shapes, structures, and even 
textures. As such, physico-chemical characterization of an enabling material is necessary to establish 
control of nanoparticle synthesis and application, and to determine the effect of associated properties 
on device performance. Importantly, the characterization technique should match the intended use of 
the device. The use of nanotechnology for IVD applications will rarely represent a biocompatibility risk 
to the patient beyond a similar device that does not involve nanotechnology. However, manufacturing 
processes involving nanotechnology may affect device effectiveness, quality, or performance [22, 25]. 
CDRH may consider these and other factors when evaluating a device. 
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Navigating the Regulatory Process 
Ronald Williams  
Environmental Protection Agency2 
The EPA has identified six “criteria pollutants” as air pollutants of particular concern because of their 
impact on public health and the environment [29]. These criteria pollutants are ozone (O3) [30], 
particulate matter [31], carbon monoxide (CO) [32], nitrogen dioxide (NO2) [33], sulfur dioxide (SO2) 
[34], and lead (Pb) [35]. Under the Clean Air Act, the EPA has established primary and secondary 
National Ambient Air Quality Standards (NAAQS) for these six pollutants. Primary standards are 
designed to protect public health, particularly sensitive populations, while secondary standards are 
designed to protect the public welfare, which includes the environment. If a geographical area does not 
meet one or more of the NAAQS, it is designated as a non-attainment area and a plan must be designed 
and implemented to meet the standard [36]. 
The current monitoring network for criteria pollutants is comprised of monitors that meet Federal 
Reference Method (FRM) or Federal Equivalent Method (FEM) requirements. Monitors are operated by 
State, local, and tribal air pollution regulatory agencies across the United States to assess pollutant 
concentrations relative to the NAAQS. A variety of instruments and techniques are needed to measure 
specific pollutants. Regulatory monitoring generally requires very sophisticated and well-established 
instrumentation to meet measurement accuracy requirements and an extensive set of procedures (e.g., 
calibration, maintenance, audits, and data validation) [37] to ensure the collection of high-quality data 
(refer to 40 CFR, Parts 50, 53, and 58, and the EPA Quality Assurance Handbook for Air Pollution 
Measurement Systems, Volume II, for activities/criteria for monitoring network data). The overall quality 
and credibility of measurements are determined by both the type of measurement instrument and how 
it is operated. 
Under the Clean Air Act, EPA regulates a list of 187 hazardous air pollutants, commonly referred to as 
“air toxics.” National Air Toxics Trends Stations (NATTS) were set up across the United States to monitor 
air toxics [38]. These stations ensure that quality data is collected in a consistent manner. Starting in 
2003, EPA has worked with State and local partners to develop the NATTS program to monitor several 
air toxics. The principal objective of the NATTS network is to provide long-term monitoring data across 
representative areas of the country for priority pollutants, including benzene, formaldehyde, 1,3-
butadiene, hexavalent chromium, and polycyclic aromatic hydrocarbons such as naphthalene, in order 
to establish overall trends. Additionally, some regulated industrial sources are required to submit air 
toxics emissions information to the EPA. The quality and completeness of emissions data varies 
significantly by region and source. 
 
                                                          
2 All opinions expressed here are those of Dr. Williams and do not reflect official EPA policy on nanotechnology. 
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3. Federal Programs and 
Resources to Support Sensor 
Development 
Member agencies of the Sensors NSI participate in all stages of the life cycle noted in Chapter 1. This 
includes supporting basic research and development, providing state-of-the-art fabrication facilities, 
developing standards, serving as regulatory authorities, and in many cases, serving as the end users for 
nanosensors. As a result, these NNI member agencies have put in place multiple mechanisms to support 
nanosensor development and nanomaterials characterization. Detailed information on various 
resources for sensor development is included in the Sensors NSI portal [1]. Through the NSI, Federal 
agencies foster communication, coordinate efforts in regulation, and promote deployment of sensors 
developed with agency support to meet sensing needs across participating agencies [3]. 
Federal agencies recognize the considerable potential for nanotechnology to enhance the development 
of inexpensive, portable devices that can rapidly detect, identify, and quantify biological and chemical 
substances. Several resources have been established to support the sensor community, including 
funding opportunities and user facilities at government laboratories and facilities. Examples of relevant 
Federal programs include the EPA National Center for Environmental Research [39], the FDA Office of In 
Vitro Diagnostics and Radiological Health [40] (formerly called the Office of In Vitro Diagnostic Device 
Evaluation and Safety), the National Cancer Institute (NCI) Alliance for Nanotechnology in Cancer [41], 
the NCI Innovative Molecular Analysis Technologies Program [42], and the recently established Center 
for Direct Reading and Sensor Technologies of the National Institute for Occupational Safety and Health 
(NIOSH) [43], among many others. 
Government laboratories and facilities continue to be an invaluable resource for the development of 
emerging technologies, including sensor nanotechnologies. Examples of government facilities and 
resources available for the development of nanosensors include the National Institute of Standards and 
Technology Center for Nanoscale Science and Technology [44], EPA’s Air Sensor Toolbox for Citizen 
Scientists [45], the NCI Nanotechnology Characterization Lab [46] and Antibody Portal [47], the NIOSH 
Field Studies Team [48], and the Department of Energy Nanoscale Science Research Centers [49]. This 
sensing infrastructure is augmented by various Federal centers and networks to support 
multidisciplinary research, advance knowledge, and enhance the transition of basic research results to 
the development of devices and other applications. 
Federal agencies continue to determine regulatory approaches that encourage the continued 
development of innovative, safe, and effective products that use nanoscale materials, including 
nanosensors. NNI agencies identify and recommend ways to address any knowledge or policy gaps that 
exist so as to evaluate possible adverse health effects from products that use nanoscale materials. 
Examples of Federal regulatory resources for the responsible development of nanosensors include the 
CPSC Small Business Ombudsman [50] and the FDA final guidance documents on the use of 
nanotechnology in consumer products [24]. 
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4. Key Challenges in the 
Development of Sensor 
Technologies 
A fundamental goal of the Sensors NSI is the development of technologies that enable next-generation 
sensing of biological and chemical materials, including those on the nanometer scale [3]. As described in 
Chapter 1, agencies participating in the Sensors NSI address this goal through two primary thrusts in 
sensing R&D: Thrust 1 for developing nanotechnology-enabled biological and chemical sensors, and 
Thrust 2 for detecting and identifying engineered nanomaterials across their life cycles. As researchers 
and businesses develop nanosensor technologies in these two topics areas, they face several key 
challenges related to standards, development and validation, manufacturing, and commercialization. A 
summary of the workshop discussions regarding these challenges is provided below. 
Standards 
The term “standards” can include physical standards, reference materials, measurement protocols, 
documentary standards, technical specifications, guidance documents, and best practices [51]. These 
materials and documents, when appropriately developed and disseminated, can provide a valuable 
resource for sensors research and commercialization. Yet, given the complex nature of standards 
development, small startup companies may not be fully aware of existing standards or understand the 
value of using reference materials or complying with published documentary standards. 
Further, if standards are released prematurely, they may not be based on sound scientific evidence or 
represent consensus among the relevant communities. Alternatively, if standards are released too late, 
they may no longer be applicable, or companies may have to manage uncertainty while the standards 
are under development. This tension is reflected by the fact that there is a perception that there are too 
many standards in some areas and too few standards in others, such as safety and performance metrics. 
Development and Testing 
There are many potential performance specifications that sensor developers can pursue, such as 
sensitivity, specificity, speed, and reliability. However, the exact requirements for each sensor ultimately 
depend on the application. Some sensors, such as those that will be used in harsh environments, may be 
designed with more emphasis on robustness than on sensitivity. Ease of use also should be kept in mind, 
and the need for complex sample preparation procedures should be minimized. Networks of sensors 
could provide powerful information on systems such as the human body, the environment, and climate, 
among many others. Yet, a systems-level approach to sensors development puts tremendous burden on 
the developers because it requires developing strategies—for example, for information management 
and network performance evaluation—that may be outside of their core areas of expertise. 
As researchers develop and test new sensor technologies, a primary challenge is access to rapid and 
precise characterization tools. In particular, more high-throughput, quantitative tools are needed to aid 
the development of sensors for nanomaterials. There is also strong demand for new computational tools 
that provide materials and risk models. 
Ideally, new sensor technologies will undergo extensive calibration and validation, including long-term 
tests, to ensure performance and reliability. The validation process should include tests under actual 
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working conditions, which could involve variations in temperature and humidity, vibration, or dusty 
operating conditions. Validation must also include tests for false positives. Small business cannot afford 
to set up individual testing and validation facilities, and workshop participants indicated that more 
testbed user facilities are greatly needed. However, testbed requirements strongly depend on the 
sensor’s application and potential regulatory considerations (e.g., health, food, pharmaceutical, 
environmental, or defense). Thus, testbeds designed for the sensors’ intended uses would be much 
more valuable than general-purpose facilities. Testing facilities must also protect businesses’ intellectual 
property and ensure reliability in measurements to maintain credibility. Finally, testbeds should be 
developed in tandem with appropriate standards to ensure maximum applicability and relevance of 
both the testbeds and the standards. 
Manufacturing 
The most pressing manufacturing challenge identified by workshop participants is the scarcity of 
nanofabrication facilities that can produce small batches of devices on a scale necessary for field testing 
at a reasonable price and with short turnaround time. In the absence of access to such cost-effective 
foundries in the United States, companies may need to consider whether to manufacture their products 
abroad. However, assembling sensors overseas can be slow and can raise questions about the security 
of intellectual property. Also, if the final product will be acquired by the Department of Defense, it may 
be subject to export controls and may need to be manufactured domestically [52]. 
In this context, it can be difficult for small businesses to identify manufacturing facilities for the 
production of an entire device. For example, some sensors need complicated sample-acquisition 
components, while others need optical components that cannot be outsourced. The systems-level 
approach presents a unique challenge in light of mass-production requirements, export restrictions, and 
intellectual property concerns, as well as cost and time constraints. Once a suitable manufacturing 
facility is found, the manufacturing process needs to be simple and cost effective. Quality control 
procedures are still needed to ensure repeatability and reproducibility in high-throughput settings. In-
line sampling would be ideal but may be prohibitively expensive. Collaboration among the 
manufacturers, government, and research laboratories is needed to develop appropriate quality control 
tools for the sensors industry. 
Finally, workforce education, training, and safety must be considered for all aspects of the development 
cycle. During the R&D phase, highly skilled industrial and software engineers are needed to design and 
fabricate prototypes and the software that operates the sensors. In the manufacturing phase, more mid-
level technical training and standard operating procedures are needed. Finally, the safety and health of 
the entire workforce needs to be a central goal when designing and implementing manufacturing 
systems, and workers should be trained in the safe handling of engineered nanomaterials. 
Commercialization 
Environmental, health, and safety considerations, including life cycle analysis and regulatory approval, 
are crucial components of successful commercialization of all sensors. Yet, many businesses are unsure 
of which regulatory agencies have purview and which statutes apply to their products. This uncertainty 
can slow down the development and commercialization of new sensor technologies. Medical device 
companies can use FDA’s pre-submission program [53] to get feedback on what data will be requested 
during regulatory review. However, this resource is underutilized, and some commercial organizations 
still report difficulty in identifying which specific aspects of nanotechnology-enabled sensor technologies 
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need to be considered before commercial use. Businesses have also called for regulations tailored to the 
scale of production. For example, the quantity of carbon nanotubes used in composites such as cement 
is many orders of magnitude larger than that used in individual sensors [11]. Finally, life cycle analysis of 
nanotechnology-enabled sensors is more complex than that of conventional sensors because 
nanomaterials may undergo transformations, such as the formation of surface films or particle 
aggregates, throughout their manufacture, use, and disposal. Example of research on the nature and 
implications of these transformations can be found in the Progress Review on the Coordinated 
Implementation of the 2011 NNI Environmental, Health, and Safety Research Strategy [54]. 
In addition to standard product liability considerations, companies must anticipate how consumers will 
interact with and operate their sensors. Consumers may use products in ways the producers did not 
intend, which could open up new markets or result in new risks to the consumer and pose liability 
concerns for the company. One specific example is the impact of the sensor–user interface on intended 
product use. Although software development might not fall within the initial phases of sensor design, it 
is an integral component of the sensor system that regulators will consider during product review [55]. 
Further, as portable sensors make home testing kits more common, companies should design their 
sensors to minimize the chances that consumers will misinterpret the sensor readings. 
Venture capitalists generally can be reluctant to invest in projects that have relatively long development 
timelines and inconsistent returns. For example, venture capital accounts for less than 5% of 
nanotechnology funding [56]. Workshop participants suggested that the scarcity of venture funds also 
extends to the development of nanosensors. Yet, there is still a need for financial support throughout 
the sensor development cycle. As such, small businesses may need to consider alternative finance 
strategies, such as matchmaking services, crowdfunding, and strategic partners. 
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5. Identifying Next Steps for 
Accelerating Nanosensor 
Development in the United States 
Sensor developers and the Federal Government can take a range of actions to address the standards, 
validation, manufacturing, and commercialization challenges that were identified at the workshop and 
summarized in Chapter 4. The sections below describe specific approaches discussed at the workshop 
for each type of challenge, as well as several cross-cutting themes and best practices that can be applied 
across the development cycle: leveraging resources, proactive planning, and timely and ongoing 
communication.  
Standards 
The Federal Government plays an important role in the development and use of standards. At times this 
role includes direct contributions to standards development, while in some specific instances it is 
appropriate for the Government to convene relevant groups and facilitate key conversations. In the 
United States, standards and specification setting is led by industry, is responsive to market needs, and 
drives technology development and innovation. For example, if industry stakeholders agree to use a 
similar methodology, groups could share equipment and tool time during early, low-volume production 
runs. Industry participation in standards setting is especially important to ensure that the resulting 
standards are balanced and enable trade and competitiveness. 
An overarching organizational framework for standards would be valuable to many stakeholders, 
particularly those who are not directly involved in the standards development process but who are 
impacted by the final published documents [57]. Ideally, such a framework would include broad overview 
standards based on intended use and more detailed specific subparts. The International Organization for 
Standardization’s 10993 document for biological evaluation of medical devices [58] is an example of such a 
broad framework. To further clarify the standards landscape, relevant standards information has been 
added to the Sensors NSI portal based on discussions at this workshop [59, 60]. 
Testing 
As outlined in Chapter 4, limited access to testbeds is a key challenge for sensor developers. Given the 
scarcity of test facilities, the National Nanotechnology Coordination Office (NNCO) has added a list of 
available user facilities to the Sensors NSI portal, under testing and commercialization support for sensor 
development [61]. The updated web portal also includes information on standard reference materials 
that could be used in performance tests. Public and private resources should be leveraged, shared when 
appropriate, and expanded to increase availability of and access to critical test facilities. 
The development and distribution of reference test kits may present a cost-effective, complementary 
alternative to the construction of new testing facilities. Ideally, these kits could be used to economically 
and reliably test sensors at users’ home institutions or in the field to replicate the sensors’ intended 
operating conditions. In addition, reference test kits could provide a method for sensor developers to 
compare the performance of their new sensor candidates to current sensors under similar test 
conditions.  
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Manufacturing 
Several potential approaches identified at the workshop could be applied to increase the availability of 
and access to fabrication facilities, which is one of the most pressing sensor manufacturing challenges, 
as described in Chapter 4. To increase the number of available foundries, small companies could help 
guide the needs for shared fabrication facilities, including manufacturing batch volumes and duration 
cycles. To improve awareness of the facilities that are currently available, the NNCO, in collaboration 
with member agencies of the Sensors NSI, has included a list of federally supported foundries for 
nanomaterials and devices on the Sensors NSI portal facilities page [62]. Further, Federal agencies can 
promote innovations in manufacturing technologies through the use of precompetitive prizes and 
challenges. Sensor developers also should plan proactively for the manufacture of their products. This 
planning should occur as early as possible in the development phase. 
Commercialization 
Participants suggested events to promote matchmaking between potential partners or between 
businesses and potential customers. This matchmaking could be accomplished by encouraging relevant 
associations and societies to hold partnering sessions at existing conferences or by the Sensors NSI 
agencies organizing matchmaking events, which is in line with recommendations from the President’s 
Council of Advisors on Science and Technology in 2014 [63]. The NNCO and agencies participating in the 
Sensors NSI could also curate and share a collection of best practices in commercialization. This 
collection could include case studies and lessons learned from companies that have successfully 
traversed the “valley of death” (between development and successful commercialization) to bring their 
products to market. Further, the portfolio of best practices could include successful approaches used by 
university technology transfer offices. 
One particularly effective practice that businesses can employ is proactive planning for 
commercialization and regulatory approval. Early market analysis can guide the development process 
because the sensors can be designed, for example, for specific working conditions or performance 
parameters. Additionally, sensor developers should determine why their products would be attractive to 
potential customers as early as possible—ideally during the mission evaluation stage. An innovative 
technical design is not sufficient for successful commercialization; the final product must create tangible 
value for the customer.  
Early communication between regulators and businesses could facilitate better awareness of the 
regulatory approval process. In this case, sensor developers would get timely access to information on 
requirements they will have to meet, such as required tolerances or acceptable deviations. Businesses 
should approach regulators early in the development process, and regulatory agencies should also 
improve their outreach, engagement, and education strategies to clarify regulatory approval 
requirements and processes. For example, as described in Chapter 4, some companies are seeking 
clarity on which agencies have jurisdiction over their products. In response to feedback at the workshop, 
information has been added to the Sensor NSI portal to summarize regulatory resources for sensing 
nanomaterials [64, 65]. 
Cross-Cutting Approaches 
Three cross-cutting best practices emerged from the workshop discussions: leveraging resources, 
proactive planning, and enhanced communication. In resource-constrained environments, it is critical 
for businesses and the Federal Government to leverage resources and build critical facilities, such as 
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testbeds and pilot-scale foundries, that multiple users can access. Proactive planning includes 
considerations of manufacturing and regulatory requirements, as well as market potential, early in the 
development process. Enhanced communication includes improved engagement among researchers, 
developers, manufacturers, customers, and the Federal Government. In response to discussions at the 
workshop, the Sensors NSI portal [1] was created to share information on the sensors development 
landscape, including funding opportunities, available facilities, regulatory guidance documents, and 
published standards. Future collaborative efforts, such as this workshop, will be the key to meeting 
agencies’ sensing needs and more efficiently ushering nanosensing products to market. 
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Appendix A. Collaborating Agencies 
Participating in the Sensors NSI3 
                                                          
Collaborating Agency Description 
Consumer Product Safety 
Commission (CPSC)
 
CPSC staff support the responsible research and development of nanotechnology for 
implementation in innovative rapid sensing and monitoring devices to improve safety 
for consumers. The development of novel sensitive, discriminative, and low-cost 
nanosensors for use in consumer products to detect prehazardous conditions and to 
provide warning or enable preventive action can reduce the likelihood of deaths and 
injuries. CPSC staff will provide support to the NSET Subcommittee on currently 
available tools, standards, and approaches to assess the safety, efficacy, quality, and 
performance of products under CPSC’s jurisdiction. 
Defense Threat Reduction 
Agency (DTRA)
 
DTRA supports the discovery and development of analytical methods and enabling 
nanomaterials for rapid and sensitive detection and identification of chemical and 
biological threats and of new materials to enhance protection against such threats. 
DTRA also supports the discovery of diagnostic methods for identifying biomarkers 
indicative of exposure or infection by biological agents, and new approaches in sensor 
data analysis and algorithms for threat detection. 
Environmental Protection 
Agency (EPA)
 
The National Center for Environmental Research (NCER) at the EPA has supported 
research in the development of innovative and rapid sensing and monitoring devices. 
These devices enable accurate assessment of the environment as well as identification 
and quantification of environmental contaminants. The research was accomplished 
through the Science to Achieve Results (STAR) grants program. Additionally, the EPA 
used the Small Business Innovation Research program as the means by which promising 
technologies, such as sensors, were solicited and funded. 
Food and Drug 
Administration (FDA)
FDA supports the responsible development of nanotechnology, including products 
relevant to nanosensors. FDA will provide guidance on currently available tools, 
standards, and approaches, as appropriate, to assess the safety, efficacy, quality, and 
performance of FDA-regulated products that may incorporate nanomaterials or 
otherwise involve the application of nanotechnology. 
National Aeronautics 
and Space 
Administration (NASA) 
 
NASA currently develops nanosensors that are highly sensitive and miniaturized, and 
that have low power consumption, for detection of chemical and biological species. 
Applications for these sensors include incorporation into lab-on-a-chip technologies for 
crew health monitoring, water quality monitoring in the International Space Station, 
and detection of biomarkers in planetary exploration. NASA also develops 
nanotechnology-based chemical sensors for a variety of gases and vapors encountered 
in planetary exploration, Earth monitoring, and aircraft and spacecraft vehicle safety. 
NASA is also working on the development of nanosensors to measure mechanical strain 
and detect the early onset of damage in structural materials for use in structural health 
monitoring for aircraft and spacecraft. The technology and test bed platforms are 
generic to leverage for biomedical and security applications. 
3 Please note that “collaborating agencies” is meant in the broadest sense and does not necessarily imply that agencies provide 
additional funds or incur obligation to do so. Agencies are listed in alphabetical order. 
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National Institutes of 
Health (NIH) NIH supports nanosensor R&D programs in biomarker discovery and validation, 
platform development for multiplexed biomarker detection (including microfluidics 
platforms, proteomic devices, and surface-enhanced Raman spectroscopy 
instrumentation), multi-analyte arrays for exposure monitoring (both point-of-contact 
and biomonitoring), molecular probes, DNA sequencing and bioinformatics, and 
characterization of nanoparticles in vivo. 
National Institute for 
Occupational Safety and 
Health (NIOSH) 
 
The NIOSH Nanotechnology Research Center (NTRC) has designated applications of 
nanotechnology for occupational safety and health as one of the 10 critical areas in its 
organized program of research to identify, investigate, and develop science-based 
solutions to workplace health and safety knowledge gaps. Through activities such as its 
Manual of Analytical Methods, NIOSH supports development of guidelines and 
voluntary consensus standards for identification of sensor needs and objectives; 
methods development, testing, and certification; user training, documentation, and 
improvement; sensor acceptance, calibration, and reliability checks; evaluation of 
operational experience; and periodic performance testing, including realistic 
applications in complex workplace situations. NIOSH also partners and conducts sensor-
related work through the NIOSH Center for Direct Reading and Sensor Technologies. 
National Institute of 
Standards and 
Technology (NIST)
 
The NIST laboratories are developing a variety of measurement methods to 
characterize nanosensors and nanomaterials and are creating nanosensors and 
nanomaterials for measurement applications and standards. Nanoscale reference 
materials developed at NIST support the validation of new sensing platforms. The NIST 
Center for Nanoscale Science and Technology user facility provides access to the tools 
and processes needed to accelerate the commercialization of nanosensor systems. 
Research addressing information quality, integrity, and usability will contribute to the 
reliability and security of sensor networks and data analysis. NIST’s complementary 
nanoEHS programs and projects support the safe manufacture, use, and disposal of 
engineered nanomaterials and nanotechnology-enabled products. 
National Science 
Foundation (NSF)
 
Through its Biosensing, Biophotonics, and other programs, NSF supports development 
of novel sensitive, discriminative, low-cost, and easy-to-operate biosensing systems; 
innovative ideas in the development of novel biorecognition strategies; multifunctional 
nanomaterials and interfaces with predefined physical, chemical, or biological 
characteristics for biosensing applications; and fundamental study of 
biomacromolecules confinement and orientation at the micro- and nanoscale 
interfaces for biosensing applications. NSF also supports the development of sensors to 
detect engineered nanoparticles in a variety of environmental matrices. 
National Institute for 
Food and Agriculture 
(NIFA, part of the United 
States Department of 
Agriculture) 
 
NIFA’s activities in nanotechnology for biosensors support its mission, strategic goals, 
and high priorities and apply broadly to plant and animal production systems, food 
quality and safety, nutrition and health, the environment, and nano-biomaterials. The 
primary thrusts are in the following areas: (1) develop novel technologies for 
characterizing fundamental nanoscale bioprocesses; (2) construct and characterize self-
assembled nanostructures; (3) develop nanoscale devices and systems incorporating 
micro-fabrication and nanotechnology; (4) develop a framework for economic, 
environmental, and health risk assessment for nanotechnologies applied to food, 
agriculture, and biological systems; and (5) produce education and outreach materials 
on nanofabrication, sensing, systems integration, and application risk assessment. 
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Appendix B. Meeting Materials 
Meeting Agenda  4
Day 1 
8:46 ***September 11th: Moment of Silence Observed*** 
9:00 Welcome Remarks 
Lloyd Whitman –NNCO 
9:15 Overview of the Sensors NSI, Purpose of Workshop 
Lisa Friedersdorf –NNCO 
9:30 Keynote presentation –Case Study on Commercialization Success 
Ernest Streicher –John Deere 
10:45 Keynote presentation –Navigating from Lab to Market 
Sydney Ulvick –In-Q-Tel 
11:30 Keynote presentation –Navigating the Regulatory Process 
Kevin Lorick –FDA/CDRH 
13:30 Keynote presentation –Navigating the Regulatory Process 
Ronald Williams –EPA 
14:00 Small Business Panel: Nanotechnology for Sensors and Sensors for Nanotechnology: 
Challenges Faced in the Commercialization of Sensors 
Abhishek Motayed –N5Sensors (Presentation) 
Ray Chen –Omega Optics (Presentation) 
Steve Gibbons –Brewer Science, Corp. (Presentation) 
Omowunmi Sadik –Binghamton University (Presentation) 
16:00 Summary of Request for Information 
Dorothy Farrell –NIH/NCI 
16:30 Recap and Preview of Day 2 
Lisa Friedersdorf –NNCO 
16:45 Poster Session and Networking 
  
                                                          
4 NOTE: The original full agenda, including times for coffee and lunch breaks, as well as links to presentation slides, biographies, and 
abstracts, may be found at the NNI workshop webpage, www.nano.gov/2014SensorsWorkshop. This agenda version notes substantive 
activities only. The links are to speaker biographies and to presentations. 
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Day 2 
8:30 Opening Remarks –Charge to Participants 
Dorothy Farrell –NIH/NCI 
8:45 Federal Panel –Programs and Resources to Support Sensor Research and Development: 
Eddie Chang –NSF (Presentation) 
Hongda Chen –NIFA (Presentation) 
Dorothy Farrell –NCI 
Mark Hoover –NIOSH (Presentation) 
Kim Sapsford –FDA 
Steve Semancik –NIST (Presentation) 
Paul Shapiro –EPA 
Treye Thomas –CPSC (Presentation) 
10:30 Breakout Session I: Standards and Testing 
13:00 Breakout Session II: Manufacturing and Commercialization 
14:30 Breakout Session Reports 
Mark Hoover –NIOSH 
15:45 Identification of Key Challenges –Next Steps  
Dorothy Farrell –NIH/NCI  
Lisa Friedersdorf –NNCO 
17:15 Summary and Closing Comments 
Treye Thomas –CPSC 
Breakout Session Topics and Discussion Points 
Breakout I: Standards 
• What existing standards have helped in measuring sensor performance in meeting desired 
specifications? 
• What standards need to be developed (for performance or manufacturing) to meet 
industry/consumer expectations for emerging sensor technologies? 
• What have you done so far to overcome challenges related to the absence of standards for 
certain stages of sensors development? 
Breakout I: Testing 
• What facilities for testbeds have you used to develop nanosensors? 
• What additional testing facilities would aid the sensor development community in improving 
sensor performance or manufacturability? 
• What sample types have you utilized to develop convincing demonstrations of sensor 
performance, and how were these samples obtained? 
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• What have you done so far to overcome challenges related to unavailability of testbed facilities 
or test samples? 
Breakout II: Manufacturing 
• Are there unique challenges in manufacturing nanosensors, and if so, how can they be 
successfully addressed? 
• What are the main technical issues in scaling-up the manufacture of sensors, and how can they 
be addressed? 
• Are there any unique workforce issues, and if so, how can they be addressed? 
• What new integration, engineering, and manufacturing tools are needed to facilitate the 
engineering and manufacture of sensors? Do these tools already exist, and are they properly 
deployed in nanosensor engineering and manufacturing? 
• What lessons have been learned that would be useful to pass on to those who contemplate 
manufacturing nanosensors? 
Breakout II: Commercialization 
• What are the primary challenges faced for nanosensor commercialization when trying to 
traverse the “valley of death,” and how can they best be addressed? 
• How best can various public and private sector funding sources be identified and used at the 
various stages of sensor development and commercialization? Are there sources that are 
currently underutilized? 
• How can market potential (e.g., size of market, competition) best be assessed at early stages in 
the development and commercialization process? 
• What, if any, regulatory challenges exist to nanosensor development? How can regulatory 
challenges for commercializing sensors be addressed? 
• What lessons have been learned that would be useful to pass on to those who contemplate 
developing and commercializing sensors? 
• What are the greatest needs and opportunities for developing nanosensors now and in the 
future? 
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Frank Huband 
World Technology Evaluation 
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5 NOTE: Participants’ affiliations are as of the date of the workshop. 
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Appendix D. List of Acronyms 
CDRH Center for Devices and Radiological Health (FDA) 
CFR Code of Federal Regulations 
CPSC Consumer Product Safety Commission 
EPA U.S. Environmental Protection Agency 
FDA Food and Drug Administration 
IDE investigational device exemption 
IQT In-Q-Tel (not-for-profit intelligence-related technology investment organization) 
IVD in vitro diagnostic device 
NAAQS National Ambient Air Quality Standards 
NATTS National Air Toxics Trends Stations 
NCI  National Cancer Institute (NIH) 
NCL  Nanotechnology Characterization Lab (NIH) 
NIFA National Institute for Food and Agriculture (USDA) 
NIOSH National Institute for Occupational Safety and Health (U.S. Centers for Disease Control 
and Prevention) 
NNCO National Nanotechnology Coordinating Office of the NNI 
NNI  National Nanotechnology Initiative 
NSET Nanoscale Science, Engineering, and Technology Subcommittee of the National Science 
and Technology Council’s Committee on Technology 
NSF  National Science Foundation 
NSI Nanotechnology Signature Initiative of the National Nanotechnology Initiative 
PMA Premarket Approval 
RFI  request for information  
Sensors NSI Nanotechnology Signature Initiative Nanotechnology for Sensors and Sensors for 
Nanotechnology: Improving and Protecting Health, Safety, and the Environment 
SUNY State University of New York 
U-PAC™ Ultrasensitive portable capillary sensor (Binghamton University, SUNY) 
USDA U.S. Department of Agriculture  
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